194 related articles for article (PubMed ID: 19710104)
1. Interleukin-6 is associated with liver lipid homeostasis but not with cell death in experimental hepatic steatosis.
Sánchez-Garrido MA; Chico Y; González R; Ranchal I; González-Rubio S; Hidalgo AB; Díaz-López C; Costán G; Padillo FJ; De la Mata M; Ochoa B; Muntané J
Innate Immun; 2009 Dec; 15(6):337-49. PubMed ID: 19710104
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
[TBL] [Abstract][Full Text] [Related]
3. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy.
Veteläinen R; van Vliet AK; van Gulik TM
Ann Surg; 2007 Jan; 245(1):44-50. PubMed ID: 17197964
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
5. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis.
Li Z; Agellon LB; Allen TM; Umeda M; Jewell L; Mason A; Vance DE
Cell Metab; 2006 May; 3(5):321-31. PubMed ID: 16679290
[TBL] [Abstract][Full Text] [Related]
6. Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury.
Llacuna L; Fernández A; Montfort CV; Matías N; Martínez L; Caballero F; Rimola A; Elena M; Morales A; Fernández-Checa JC; García-Ruiz C
J Hepatol; 2011 May; 54(5):1002-10. PubMed ID: 21145825
[TBL] [Abstract][Full Text] [Related]
7. Steatotic liver allografts up-regulate UCP-2 expression and suffer necrosis in rats.
Uchino S; Yamaguchi Y; Furuhashi T; Wang FS; Zhang JL; Okabe K; Kihara S; Yamada S; Mori K; Ogawa M
J Surg Res; 2004 Jul; 120(1):73-82. PubMed ID: 15172192
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet.
Romestaing C; Piquet MA; Letexier D; Rey B; Mourier A; Servais S; Belouze M; Rouleau V; Dautresme M; Ollivier I; Favier R; Rigoulet M; Duchamp C; Sibille B
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E110-9. PubMed ID: 17986629
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylcholine protects against steatosis in mice but not non-alcoholic steatohepatitis.
Niebergall LJ; Jacobs RL; Chaba T; Vance DE
Biochim Biophys Acta; 2011 Dec; 1811(12):1177-85. PubMed ID: 21745592
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of mitochondrial glutathione-dependent hepatocellular susceptibility to TNF despite NF-kappaB activation.
Marí M; Colell A; Morales A; Caballero F; Moles A; Fernández A; Terrones O; Basañez G; Antonsson B; García-Ruiz C; Fernández-Checa JC
Gastroenterology; 2008 May; 134(5):1507-20. PubMed ID: 18343380
[TBL] [Abstract][Full Text] [Related]
11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
12. Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo.
Shen B; Yu J; Wang S; Chu ES; Wong VW; Zhou X; Lin G; Sung JJ; Chan HL
Hepatology; 2008 Feb; 47(2):473-83. PubMed ID: 18157836
[TBL] [Abstract][Full Text] [Related]
13. Reversal of hepatic steatosis by omega-3 fatty acids measured non-invasively by (1) H-magnetic resonance spectroscopy in a rat model.
Marsman HA; Heger M; Kloek JJ; Nienhuis SL; van Werven JR; Nederveen AJ; Ten Kate FJ; Stoker J; van Gulik TM
J Gastroenterol Hepatol; 2011 Feb; 26(2):356-63. PubMed ID: 21261727
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
[TBL] [Abstract][Full Text] [Related]
15. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
16. The pro-inflammatory action of tumour necrosis factor-α in non-alcoholic steatohepatitis is independent of the NSMAF gene product.
Mas E; Danjoux M; Garcia V; Carpentier S; Ségui B; Levade T
Dig Liver Dis; 2013 Feb; 45(2):147-54. PubMed ID: 23044079
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial glutathione: hepatocellular survival-death switch.
Garcia-Ruiz C; Fernandez-Checa JC
J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S3-6. PubMed ID: 16958667
[TBL] [Abstract][Full Text] [Related]
18. Increased susceptibility of fat-laden Zucker-rat hepatocytes to bile acid-induced oncotic necrosis: an in vitro model of steatocholestasis.
Kobak GE; Dahl R; Devereaux MW; Gumpricht E; Traber M; Doctor RB; Sokol RJ
J Lab Clin Med; 2005 May; 145(5):247-62. PubMed ID: 15902097
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes.
Zhang X; Li ZZ; Liu DF; Xu X; Mei ZC; Shen W
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):631-6. PubMed ID: 19076162
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease.
Zhang W; Kudo H; Kawai K; Fujisaka S; Usui I; Sugiyama T; Tsukada K; Chen N; Takahara T
Biochem Biophys Res Commun; 2010 Jan; 391(4):1731-6. PubMed ID: 20043871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
